期刊
JOURNAL OF IMMUNOLOGY
卷 181, 期 10, 页码 7350-7355出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.10.7350
关键词
-
类别
资金
- Benaroya Research Institute
- Juvenile Diabetes Research Foundation Center for Translational Research
- Juvenile Diabetes Research Foundation [33-2008-398]
- Dana Foundation [R01 DK072457]
- Deutsche Forschungsgemeinschaft [1083/2-1]
Defects in immune regulation have been implicated in the pathogenesis of diabetes in mouse and in man. In vitro assays using autologous regulatory (Treg) and responder effector (Tell) T cells have shown that suppression is impaired in diabetic subjects. In this study, we addressed whether the source of this defect is intrinsic to the Treg or Teff compartment of diabetic subjects. We first established that in type I diabetes (T1D) individuals, similar levels of impaired suppression were seen, irrespective of whether natural (nTreg) or adaptive Treg (aTreg) were present. Then using aTreg, we examined the ability of T1D aTreg to suppress Teff of healthy controls, as compared with the ability of control aTreg to suppress Teff of diabetic subjects. Taking this approach, we found that the aTregs from T1D subjects function normally in the presence of control Teff, and that the T1D Teff were resistant to suppression in the presence of control aTreg. This escape from regulation was seen with nTreg as well and was not transferred to control Teff coincubated with T1D Teff. Thus, the defective regulation in T1D is predominantly due to the resistance of responding T cells to Treg and is a characteristic intrinsic to the T1D Teff. This has implications with respect to pathogenic mechanisms, which underlie the development of disease and the target of therapies for T1D. The Journal of Immunology, 2008, 181: 7350-7355.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据